biotech · Dental Caries · Cystic Fibrosis · ARMP
Armata Pharmaceuticals
Armata Pharmaceuticals clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Freehold, USA
- Founded
- 2018
- Employees
- 18
- Programs
- 9
- Drugs
- 0
- Patents
- 5
Armata Pharmaceuticals projects
9 ClinicalTrials.gov programs sponsored by Armata Pharmaceuticals.
Armata Pharmaceuticals has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AP-PA02
Armata Pharmaceuticals
Non-cystic Fibrosis Bronchiectasis
1 trial -
AP-PA02
Armata Pharmaceuticals
Cystic Fibrosis
1 trial -
AP-SA02
Armata Pharmaceuticals
Bacteremia
1 trial -
C16G2
Armata Pharmaceuticals
Dental Caries
3 trials -
C16G2 Gel
Armata Pharmaceuticals
Dental Caries
1 trial -
C16G2 Rinse
Armata Pharmaceuticals
Dental Caries
1 trial -
C16G2 Strip
Armata Pharmaceuticals
Dental Caries
1 trial -
C16G2 Varnish
Armata Pharmaceuticals
Dental Caries
1 trial -
AB-SA01 (10^8 PFU per phage)
Armata Pharmaceuticals
Healthy Volunteers
1 trial
Frequently asked questions
How many clinical projects does Armata Pharmaceuticals have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.